双能CT碘定量在肝脏肿瘤中的应用:扫描、患者及位置相关因素的影响
本研究采用体模模拟四种肝脏病灶(直径15 mm,碘浓度0-5 mgI/mL)和两种尺寸,在双源双能CT(100/Sn150 kV)与单源分滤双能CT(AuSn120 kV)下于两种辐射剂量和七种垂直检查床位置进行扫描,评估碘定量绝对误差。结果显示双能采集方式、体模尺寸和病灶位置显著影响误差,单源分滤双能CT误差显著高于双源双能CT,辐射剂量无显著影响。
要点
- 双源双能CT的碘定量绝对误差(0.37±0.29 mgI/mL)显著低于单源分滤双能CT(2.08±1.92 mgI/mL)。
- 膈下病灶在单源分滤双能CT下出现伪影,且绝对误差较双源双能CT显著增高。
- 大尺寸体模的绝对误差在双源双能CT(0.43±0.33 mgI/mL)和单源分滤双能CT(2.36±1.81 mgI/mL)下均显著高于中尺寸体模。
关键影像表现/征象
- 单源分滤双能CT下膈下病灶出现伪影,其绝对误差较双源双能CT显著增高(p<0.001)。
- 单源分滤双能CT的绝对误差(2.08±1.92 mgI/mL)显著高于双源双能CT(0.37±0.29 mgI/mL)(所有p<0.001)。
- 双源双能CT中大尺寸体模绝对误差(0.43±0.33 mgI/mL)显著高于中尺寸体模(0.30±0.23 mgI/mL)(p<0.001)。
- 单源分滤双能CT中大尺寸体模绝对误差(2.36±1.81 mgI/mL)显著高于中尺寸体模(1.68±1.99 mgI/mL)(p<0.001)。
诊断标准与关键数值
- 线性混合效应模型显示误差受双能采集方式、体模尺寸和病灶位置显著影响(均p<0.001)。
- 辐射剂量对误差无显著影响(p=0.22)。
- 病灶位置对误差的影响在单源分滤双能CT中较双源双能CT更强。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To quantify the contribution of lesion location and patient positioning, dual-energy approach, patient size, and radiation dose to the error of dual-energy CT-based iodine quantification (DECT-IQ) in liver tumors.
MATERIALS AND METHODS: A phantom with four liver lesions (diameter 15 mm; iodine concentration 0-5 mgI/mL) and two sizes was used. One lesion emulated a subdiaphragmatic lesion. Both sizes were imaged in dual-energy mode on (1) a dual-source DECT (DS-DE) at 100/Sn150 kV and (2) a single-source split-filter DECT (SF-DE) at AuSn120 kV at two radiation doses (8 and 12 mGy). Scans were performed at seven different vertical table positions (from -6 to + 6 cm from the gantry isocenter). Iodine concentration was repeatedly measured and absolute errors (errorabs) were calculated. Errors were compared using robust repeated-measures ANOVAs with post-hoc comparisons. A linear mixed effect model was used to determine the factors influencing the error of DECT-IQ.
RESULTS: The linear mixed effect models showed that errors were significantly influenced by DECT approach, phantom size, and lesion location (all p < 0.001). The impact of lesion location on the error was stronger in SF-DE compared to DS-DE. Radiation dose did not significantly influence error (p = 0.22). When averaged across all setups, errorabs was significantly higher for SF-DE (2.08 ± 1.92 mgI/mL) compared to DS-DE (0.37 ± 0.29 mgI/mL) (all p < 0.001). Artefacts were found in the subdiaphragmatic lesion for SF-DE with significantly increased errorabs compared to DS-DE (p < 0.001). Errorabs was significantly higher in the large compared to the medium phantom for DS-DE (0.30 ± 0.23 mgI/mL vs. 0.43 ± 0.33 mgI/mL) and SF-DE (1.68 ± 1.99 vs. 2.36 ± 1.81 mgI/mL) (p < 0.001).
CONCLUSION: The dual-energy approach, patient size, and lesion location modified by patient position significantly impacted DECT-IQ in simulated liver tumors.
引用
- Schmidt C, Baessler B, Nakhostin D, et al. Dual-Energy CT-Based Iodine Quantification in Liver Tumors - Impact of Scan-, Patient-, and Position-Related Factors. Acad Radiol. 2020. PMID: 32418783. doi:10.1016/j.acra.2020.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。